For: | Tian Y, Ding RY, Zhi YH, Guo RX, Wu SD. Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. World J Gastroenterol 2006; 12(3): 415-419 [PMID: 16489641 DOI: 10.3748/wjg.v12.i3.415] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i3/415.htm |
Number | Citing Articles |
1 |
Kshitij Srivastava, Anvesha Srivastava, Balraj Mittal. Potential biomarkers in gallbladder cancer: present status and future directions. Biomarkers 2013; 18(1): 1 doi: 10.3109/1354750X.2012.717105
|
2 |
G. Karatzas, E. Misiakos. Liver and Biliary Tract Surgery. 2006; : 267 doi: 10.1007/978-3-211-49277-2_21
|
3 |
Jeremy L. Davis, T. Peter Kingham. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 786 doi: 10.1016/B978-0-323-34062-5.00049-2
|
4 |
Olca Basturk, Alton B. Farris, N. Volkan Adsay. Diagnostic Immunohistochemistry. 2011; : 541 doi: 10.1016/B978-1-4160-5766-6.00019-4
|
5 |
Weirong Chen, Ziqun Liao, Maogen Chen, Gaoyang Cai, Tinghan Li. Significance of extracellular signal-regulated kinase (ERK) in the development of rectal carcinoma. The Chinese-German Journal of Clinical Oncology 2008; 7(1): 27 doi: 10.1007/s10330-007-0127-z
|
6 |
Yu Xia, Zhenhua Du, Xinyan Wang, Xiuqin Li. Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study ofTP53Gene Therapy. Human Gene Therapy 2018; 29(2): 242 doi: 10.1089/hum.2017.206
|
7 |
Sameer Gupta, Sudeep Garg, Vijay Kumar, Arun Chaturvedi, Sanjeev Misra, Naseem Akhtar, Shiv Rajan, Jatinder Kaur, Manikandan Lakshmanan, Kavitha Jain. Study of tumor transglutaminase 2 expression in gallbladder cancer – Is it a novel predictor of survival?. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(4): 460 doi: 10.14701/ahbps.2020.24.4.460
|
8 |
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular update. Histopathology 2009; 55(2): 218 doi: 10.1111/j.1365-2559.2008.03192.x
|
9 |
Hilla Solomon, Shalom Madar, Varda Rotter. Mutant p53 gain of function is interwoven into the hallmarks of cancer. The Journal of Pathology 2011; 225(4): 475 doi: 10.1002/path.2988
|
10 |
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
|
11 |
Melanie B Thomas. Targeted therapies for cancer of the gallbladder. Current Opinion in Gastroenterology 2008; 24(3): 372 doi: 10.1097/MOG.0b013e3282f6a7df
|
12 |
Li Chen, Yuan-Yuan Wu, Peigen Liu, Jianli Wang, Guilan Wang, Jin Qin, Jiaming Zhou, Jianwei Zhu. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells. Medical Oncology 2011; 28(S1): 528 doi: 10.1007/s12032-010-9690-1
|
13 |
M Dong, X Li, L-J Hong, R Xie, H-L Zhao, K Li, H-H Wang, W-D Shin, H-J Shen. Advanced Malignant Pleural or Peritoneal Effusion in Patients Treated with Recombinant Adenovirus p53 Injection plus Cisplatin. Journal of International Medical Research 2008; 36(6): 1273 doi: 10.1177/147323000803600614
|
14 |
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy. Cancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
|
15 |
David S. Klimstra, Olca Basturk. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 765 doi: 10.1016/B978-0-323-34062-5.00047-9
|
16 |
Melanie B. Thomas. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy. Critical Reviews in Oncology/Hematology 2007; 61(1): 44 doi: 10.1016/j.critrevonc.2006.07.006
|
17 |
Pablo Letelier, Patricia Garcia, Pamela Leal, Carmen Ili, Kurt Buchegger, Ismael Riquelme, Alejandra Sandoval, Oscar Tapia, Juan C. Roa. Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder Carcinoma. Applied Immunohistochemistry & Molecular Morphology 2014; 22(7): 530 doi: 10.1097/PAI.0b013e3182a318a9
|
18 |
Priya Rupesh, Pandey Manoj, Shukla Vijay Kumar. Biomarkers in carcinoma of the gallbladder. Expert Opinion on Medical Diagnostics 2008; 2(5): 511 doi: 10.1517/17530059.2.5.511
|
19 |
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 891 doi: 10.1007/978-1-4419-7107-4_61
|
20 |
Tian Tang, Duan-Lian Zhang. Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique. Oncology Letters 2017; 13(5): 2937 doi: 10.3892/ol.2017.5856
|
21 |
Kumudesh Mishra, Anu Behari, Vinay Kumar Kapoor, M. Salman Khan, Swayam Prakash, Suraksha Agrawal. Vascular endothelial growth factor single‐nucleotide polymorphism in gall bladder cancer. Journal of Gastroenterology and Hepatology 2013; 28(10): 1678 doi: 10.1111/jgh.12343
|
22 |
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
|
23 |
T. Peter Kingham, Michael I. D’Angelica. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 741 doi: 10.1016/B978-1-4377-1454-8.00049-7
|
24 |
Juan Carlos Roa, N. Volkan Adsay. Molecular Surgical Pathology. 2013; : 65 doi: 10.1007/978-1-4614-4900-3_4
|
25 |
Pooja Shukla, Kumudesh Mishra, Ratnakar Shukla, Ruchira Vishwakarma, Niraj Kumari, Narendra Krishnani, Anu Behari, Vinay K. Kapoor. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer. Journal of Cancer Research and Therapeutics 2024; 20(1): 349 doi: 10.4103/jcrt.jcrt_1473_22
|
26 |
Yoav Shetzer, Hilla Solomon, Gabriela Koifman, Alina Molchadsky, Stav Horesh, Varda Rotter. The paradigm of mutant p53-expressing cancer stem cells and drug resistance. Carcinogenesis 2014; 35(6): 1196 doi: 10.1093/carcin/bgu073
|
27 |
Anjali Singh, Pramod K. Mishra, Sundeep Singh Saluja, Majid A. Talikoti, Pawan Kirtani, Abul Kalam Najmi. Prognostic Significance of HER-2 and p53 Expression in Gallbladder Carcinoma in North Indian Patients. Oncology 2016; 91(6): 354 doi: 10.1159/000450999
|
28 |
Shalom Madar, Einav Harel, Ido Goldstein, Yan Stein, Ira Kogan-Sakin, Iris Kamer, Hilla Solomon, Elya Dekel, Perry Tal, Naomi Goldfinger, Gilgi Friedlander, Varda Rotter, Joseph Alan Bauer. Mutant p53 Attenuates the Anti-Tumorigenic Activity of Fibroblasts-Secreted Interferon Beta. PLoS ONE 2013; 8(4): e61353 doi: 10.1371/journal.pone.0061353
|